Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Speculative Biotech: A Speculation Trader's Dream and Nightmare
Seeking Alpha
Thursday, November 3, 2011 - 12:24pm
tags:
MannKind, Transcept, BioMimetic Therapeutics
Medivation rockets 120% on drug study
Marketwatch
Thursday, November 3, 2011 - 12:21pm
tags:
Medivation, prostate cancer, MDV3100
Pozen narrows 3Q net loss
Bizjournals.com
Thursday, November 3, 2011 - 12:20pm
tags:
earnings, Pozen
P&G raises profit outlook on Teva JV, Pringles sale
Yahoo/AP
Thursday, November 3, 2011 - 12:19pm
tags:
Teva Pharmaceuticals, P&G, guidance
Dendreon beaten down again on so-so Provenge sales update
Fierce Pharma
Thursday, November 3, 2011 - 11:37am
tags:
Dendreon, Provenge, prostate cancern
FDA Touts Pace of Its Drug Approvals Over European Counterparts
Bloomberg
Thursday, November 3, 2011 - 11:35am
tags:
FDA, drug approvals, Europe
Will Bristol-Myers Squibb Earn or Burn?
Motley Fool
Thursday, November 3, 2011 - 11:35am
tags:
Bristol-Myers Squibb, Teva Pharmaceuticals, Pfizer, Watson
Novo Nordisk Rejects China M&A; Plans Growth Through Innovation
Seeking Alpha
Thursday, November 3, 2011 - 10:59am
tags:
China, innovation, Novo Nordisk
Sanofi Profit Declines 3%, Hurt by Generic Competition
Bloomberg
Thursday, November 3, 2011 - 8:53am
tags:
Sanofi, earnings
GlaxoSmithKline to pay $3B to settle U.S. probes
Marketwatch
Thursday, November 3, 2011 - 8:52am
tags:
GSK, settlements, Medicaid, Avandia
Teva Could Market Generic Lipitor by Month’s End, Calcalist Says
Bloomberg
Thursday, November 3, 2011 - 8:51am
tags:
Teva Pharmaceuticals, generics, Pfizer, statins, Lipitor
FDA panel backs expanded use of Merck's Vytorin
Yahoo/AP
Thursday, November 3, 2011 - 8:50am
tags:
FDA, Merck, Vytorin, kidney disease
Lilly Hid Zyprexa’s Diabetes Risks, Student Died, Lawyer Argues
Bloomberg
Thursday, November 3, 2011 - 8:49am
tags:
Zyprexa, diabetes, Eli Lilly
6 Biotech Stocks Analysts Expect To Double In 2012
Seeking Alpha
Wednesday, November 2, 2011 - 11:53am
tags:
Sequenom, Incyte, Novavax, Zalicus, YM BioSciences, Alimera
Charles River's 3Q results miss Wall St. targets
Yahoo/AP
Wednesday, November 2, 2011 - 11:52am
tags:
earnings, Charles River Laboratories
Neurocrine Biosciences' Positive Surge Was Not Unexpected
Seeking Alpha
Wednesday, November 2, 2011 - 11:51am
tags:
Neurocrine, Abbott Laboratories
Jazz Pharma 3Q profit doubles as Xyrem sales rise
Yahoo/AP
Wednesday, November 2, 2011 - 11:50am
tags:
earnings, Jazz Pharmaceuticals
Targacept reports loss
Bizjournals.com
Wednesday, November 2, 2011 - 11:49am
tags:
Targacept, earnings
Depomed Reports Third Quarter 2011 Financial Results
Yahoo
Wednesday, November 2, 2011 - 11:30am
tags:
Depomed, earnings
One Pill Makes You Stronger: Pfizer Earnings Bring Strength To Your Portfolio
Seeking Alpha
Wednesday, November 2, 2011 - 11:22am
tags:
earnings, Merck, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.